Health ❯ Healthcare ❯ Pharmaceuticals

Side Effects

Gastrointestinal Issues Adverse Reactions Medication Risks Drug Safety Gastrointestinal Effects Nausea and Vomiting Adverse Events Medication Side Effects Nausea Psychiatric Effects Brain Swelling Gastrointestinal Symptoms Ozempic Teeth Allergic Reactions Drug Interactions Mounjaro Side Effects Lynkuet Gastrointestinal Distress Wegovy Adverse Effects Cough Medicine Side Effects Clinical Study Results Vaccine Side Effects Patient Outcomes Rare Adverse Effects Semaglutide Patient Safety Topical Treatments GLP-1 Agonists Weight Loss Drugs Drug Efficacy Serotonin Reuptake Inhibitors Drug Comparisons Chemotherapy Lecanemab Side Effects Hair Loss Hypophosphataemia

FDA Expands Mounjaro Label to Include Cardiovascular Risk Reduction

Regulators cited a head-to-head trial that showed about an 8% relative drop in major heart events versus Lilly’s older drug Trulicity, prompting wider use for high-risk adults with type 2 diabetes.

FDA Approves At‑Home Weekly Subcutaneous Starter Dose for Leqembi

FDA Clears Eli Lilly’s Foundayo Oral GLP-1 for Weight Loss, With U.S. Launch Set for April 6

FDA Approves Lynkuet, a Nonhormonal Pill for Menopausal Hot Flashes

Roivant’s Brepocitinib Succeeds in 52-Week Dermatomyositis Phase 3 as Companies Target 2026 FDA Filing